A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer
Clinical trial NCT00486668 · UNKNOWN
Trial details
- NCT number
- NCT00486668
- Sponsor
- NSABP Foundation Inc
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-01
- Primary completion
- 2012-06-01
- Enrollment
- 529
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.